Co-transfection of GM-CSF mRNA into tumor mRNA-loaded DCs significantly enhanced the anti-tumor efficacy of DC vaccines in CT26 tumor-bearing mice, which was associated with increased cytotoxicity of bulk splenocytes against CT26 tumor cells in vitro [80]. This evidence concerns the gene CSF2 and neoplasm.